Ajanta Pharma’s promoter entity -- Ravi Agrawal Trust has sold 34.50 lakh equity shares, representing 2.76% of total shareholding, of the company through an open market transaction worth Rs 1023.96 crore. The shares were disposed at an average price of Rs 2,968 apiece.
Meanwhile, Kotak Mahindra Mutual Fund has bought around 21.02 lakh equity shares of the company through an open market transaction worth Rs 623.96 crore. The shares have been acquired at an average price of Rs 2,968 apiece.
Ajanta Pharma is a specialty pharmaceutical formulation company having major focus on branded generic business across India, Asia & Africa.
